What is Zacks Research’s Estimate for FOLD Q1 Earnings?
Amicus Therapeutics, Inc. (NASDAQ:FOLD – Free Report) – Equities researchers at Zacks Research issued their Q1 2025 EPS estimates for Amicus Therapeutics in a note issued to investors on Tuesday, April 1st. Zacks Research analyst R. Department expects that the biopharmaceutical company will post earnings of ($0.01) per share for the quarter. The consensus estimate […]
Amicus Therapeutics, Inc. (NASDAQ:FOLD – Free Report) – Equities researchers at Zacks Research issued their Q1 2025 EPS estimates for Amicus Therapeutics in a note issued to investors on Tuesday, April 1st. Zacks Research analyst R. Department expects that the biopharmaceutical company will post earnings of ($0.01) per share for the quarter. The consensus estimate […]
